Acquired immunodeficiency syndrome-related lymphoma.
OBJECTIVE
To discuss the presentation, treatment, and aggressiveness of acquired immunodeficiency syndrome (AIDS)-related non-Hodgkin's lymphoma and AIDS-related primary central nervous system lymphoma, and to address the differences of these lymphomas in the human immunodeficiency virus (HIV)-negative individual.


METHODS
Published review articles, clinical studies, and abstracts pertaining to HIV and AIDS-related lymphomas.


CONCLUSIONS
Many believe that as the therapies and supportive care for HIV-positive individuals improve, the incidence of malignancy in this patient population will continue to increase. Great controversy exists surrounding the most effective therapies for AIDS-related lymphomas. These patients should be entered into clinical trials to test appropriate hypotheses and answer the remaining questions.


CONCLUSIONS
As the HIV epidemic continues and HIV-associated malignancies increase, the nurse must understand the co-morbidity associated with both diseases. Oncology nurses play many roles in caring for this patient population and their support and intervention contribute to the response of the patient.
Roth
E L
EL
Amgen Inc, Thousand Oaks, CA 91320-1789, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000451:nursing; D002986:Clinical Trials as Topic; D006689:Hodgkin Disease / Q000175:diagnosis / Q000451:nursing / Q000628:therapy; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000175:diagnosis / Q000188:drug therapy / Q000451:nursing; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy / Q000451:nursing; D009859:Oncology Nursing